Expression of A, B, and H blood group antigens in epithelial ovarian cancer: Relationship to tumor grade and patient survival Journal Article


Authors: Welshinger, M.; Finstad, C. L.; Venkatraman, E.; Federici, M. G.; Rubin, S. C.; Lewis, J. L. Jr; Lloyd, K. O.
Article Title: Expression of A, B, and H blood group antigens in epithelial ovarian cancer: Relationship to tumor grade and patient survival
Abstract: The expression of A, B, and H blood group antigens in epithelial ovarian cancer was evaluated in 137 patients with advanced disease by staining frozen sections with specific monoclonal antibodies using an indirect immunoperoxidase method. Expression of blood group antigens was observed in a proportion of ovarian carcinomas and in some areas of ovarian surface epithelium. Forty-eight percent of the tumors tested from 130 blood group A, B, or O individuals showed no expression of the appropriate blood group antigen, 32% had heterogeneous antigen expression, and 20% had strong expression. In the 7 blood group AB patients studied, no expression, heterogeneous expression of both antigens, or absence of one, but not the other antigen, was observed. No tumor showed A, B, or H antigen expression that was not compatible with the patient's blood group type. Histologic Grade 3 tumors showed absence of blood group antigen expression more often than did Grade 2 tumors. The presence or absence of A, B, or H antigen expression did not correlate with survival in this group of patients. This is in contrast to studies in other epithelial tumor types in which the normal epithelium synthesizes blood group antigens and loss of ABH antigen expression is observed in the corresponding tumors.
Keywords: immunohistochemistry; cancer survival; major clinical study; cancer grading; antigen expression; ovary cancer; tumor biopsy; survival time; prognosis; human; female; priority journal; article; blood group abh antigen
Journal Title: Gynecologic Oncology
Volume: 62
Issue: 1
ISSN: 0090-8258
Publisher: Elsevier Inc.  
Date Published: 1996-07-01
Start Page: 106
End Page: 112
Language: English
DOI: 10.1006/gyno.1996.0198
PUBMED: 8690281
PROVIDER: scopus
DOI/URL:
Notes: Article -- Export Date: 22 November 2017 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Venkatraman Ennapadam Seshan
    382 Seshan
  2. Kenneth O Lloyd
    163 Lloyd
  3. John   Lewis
    132 Lewis
  4. Connie L. Finstad
    45 Finstad
  5. Stephen C. Rubin
    112 Rubin